Get the Stockscreener App
4.80
122.69%
2.64
Bioxcel Therapeutics Inc Stock (BTAI) Latest News
BioXcel Therapeutics regains Nasdaq compliance - Investing.com
BioXcel Therapeutics concludes FDA site inspection - Investing.com
BioXcel Therapeutics Announces FDA Closed its Inspection of - GlobeNewswire
FDA Clears Critical Hurdle for BioXcel's Alzheimer's Agitation Drug Development - StockTitan
Top Penny Stocks To ResearchMarch 2nd - MarketBeat
Best Penny Stocks To Keep An Eye OnMarch 1st - MarketBeat
Top Penny Stocks To Watch NowFebruary 28th - MarketBeat
Sector Update: Health Care Stocks Rise in Late Afternoon Trading -February 28, 2025 at 03:54 pm EST - Marketscreener.com
Sector Update: Health Care -February 28, 2025 at 03:33 pm EST - Marketscreener.com
BioXcel Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
BioXcel Therapeutics regains compliance with Nasdaq - MSN
New Haven-based BioXcel avoids delisting from Nasdaq stock exchange - Hartford Business Journal
BioXcel Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada
Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews
BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nasdaq
BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule - GlobeNewswire
How BioXcel Therapeutics Escaped Nasdaq's Delisting Threat After Months Below $1 - StockTitan
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of BioXcel Therapeutics, Inc.(BTAI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
BTAI stock touches 52-week low at $2.53 amid sharp annual decline - MSN
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of BioXcel Therapeutics, Inc. (BTAI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
BTAI stock plunges to 52-week low of $2.16 amid market challenges - Investing.com Nigeria
BTAI stock plunges to 52-week low of $2.16 amid market challenges By Investing.com - Investing.com South Africa
SHAREHOLDER ALERT: Potential Recovery for BioXcel Therapeutics, Inc. (BTAI) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
BioXcel Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
BioXcel Therapeutics expands board, appoints new director - MSN
BioXcel Therapeutics announces 1-for-16 reverse stock split - MSN
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Update - MarketBeat
A significant driver of top-line growth: BioXcel Therapeutics Inc (BTAI) - SETE News
You Should Look At The Stock Forecast For BioXcel Therapeutics Inc (NASDAQ: BTAI). - Marketing Sentinel
BioXcel Therapeutics Inc (BTAI) Shares Down Despite Recent Market Volatility - The News Heater
The Psychology of BioXcel Therapeutics Inc Inc. (BTAI) Price Performance: Understanding Market Sentiment - The InvestChronicle
Balance Sheet Insights: BioXcel Therapeutics Inc (BTAI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential - Marketscreener.com
BioXcel Therapeutics, Inc. Appoints June Bray to its Board of Directors -March 01, 2021 at 10:13 am EST - Marketscreener.com
BioXcel Therapeutics Announces Appointment of Reina Benabou, M.D., Ph.D., as Senior Vice President and Chief Development Officer - Marketscreener.com
BioXcel Therapeutics Shares Rise Premarket on FDA Fast-Track Designation -February 12, 2024 at 07:43 am EST - Marketscreener.com
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts BioXcel Therapeutics (BTAI) Investors to Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys - ACCESS Newswire
BioXcel Therapeutics enacts 1-for-16 reverse stock split - MSN
BioXcel Therapeutics announces reverse stock split - Hartford Business Journal
BioXcel Therapeutics announces 1-for-16 reverse stock split By Investing.com - Investing.com Nigeria
BioXcel to execute 1-for-16 reverse stock split - MSN
BioXcel to Implement Reverse Stock Split; Shares Fall -February 06, 2025 at 01:28 pm EST - Marketscreener.com
BioXcel Therapeutics Announces Reverse Stock Split - citybiz
BioXcel Therapeutics enacts 1-for-16 reverse stock split By Investing.com - Investing.com Canada
BioXcel Therapeutics Sets 1-for-16 Reverse Stock Split To Regain Nasdaq Listing - Nasdaq
2.93%
1.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):